Evelo Biosciences, Inc.

OTCPK:EVLO Stock Report

Market Cap: US$7.6k

Evelo Biosciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4.8yrs
Board average tenureno data

Recent management updates

Recent updates

Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Aug 18
Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Evelo Biosciences GAAP EPS of -$0.40 beats by $0.03

Aug 11

Marella Thorell is the new finance chief of Evelo Biosciences

Jul 18

Evelo Biosciences: Hope After Dilution?

Jun 06

Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Mar 21
Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

Sep 25
Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Mar 11
What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Evelo Bio secures ~$67.5M capital raise

Jan 29

Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis

Jan 07

Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Dec 15
Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Dec 11
Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Evelo Biosciences identifies new lead oncology candidate

Dec 09

Evelo Bio's EDP1815 completes enrollment targeting interim data in mid-stage psoriasis study

Dec 03

Evelo Biosciences EPS beats by $0.04

Oct 29

CEO

Evelo Biosciences has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Craig Jalbert
Presidentless than a yearno datano data
Chun Zhang
Chief Technical Operations & Quality Officer4.8yrsno datano data
Mark Bodmer
Chief Scientific Officer and President of Research & Development8.6yrsUS$1.15m0.14%
$ 10.3
Jessica Cotrone
VP & Head of Communicationsno datano datano data
Leslie Wardwell-Scott
VP and Head of Corporate Development & Strategic Integration2.4yrsno datano data
Andrea Itano
Head of Research4.8yrsno datano data
Duncan McHale
Chief Medical Officer6.8yrsUS$1.23m0.089%
$ 6.8
Douglas Maslin
Senior Director & Immunology Clinical Leadno datano datano data

4.8yrs

Average Tenure

62yo

Average Age

Experienced Management: EVLO's management team is considered experienced (4.8 years average tenure).